EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic options

Wouter Tack iD, Anne-Marie De Cock, Eveline Lia Dirinck iD, Sophie Bastijns, Femke Ariën, Stany Perkisas

Diabetes, Obesity and Metabolism · 2024-02 · 26 (2) · 407-416

DOI: 10.1111/dom.15321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 18.10.2023. Verfasst von Wouter Tack und 5 weiteren Autor:innen. Beteiligte Einrichtung: ZNA (ZiekenhuisNetwerk Antwerpen), University Center for Geriatrics, Antwerp, Belgium. Hauptthemen laut MEDLINE: Sarcopenia, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 120 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review will try to elucidate the interconnected pathophysiology of sarcopenia and type 2 diabetes (T2D) and will try to identify a common pathway to explain their development. To this end, the PubMed and Scopus databases were searched for articles published about the underlying pathophysiology, diagnosis and treatment of both sarcopenia and T2D. The medical subject heading (MeSH) terms ‘sarcopenia’ AND ‘diabetes mellitus’ AND (‘physiopathology’ OR ‘diagnosis’ OR ‘therapeutics’ OR ‘aetiology’ OR ‘causality’) were used. After screening, 32 papers were included. It was evident that sarcopenia and T2D share multiple pathophysiological mechanisms. Common changes in muscle architecture consist of a shift in myocyte composition, increased myosteatosis and a decreased capacity for muscle regeneration. Further, both diseases are linked to an imbalance in myokine and sex hormone production. Chronic low‐grade inflammation and increased levels of oxidative stress are also known pathophysiological contributors. In the future, research efforts should be directed towards discovering common checkpoints in the development of T2D and sarcopenia as possible shared therapeutic targets for both diseases. Current treatment for T2D with biguanides, incretins and insulin may already convey a protective effect on the development of sarcopenia. Furthermore, attention should be given to early diagnosis of sarcopenia within the population of people with T2D, given the sizeable physical and medical burden it encompasses. A combination of simple diagnostic techniques could be used at regular diabetes check‐ups to identify sarcopenia at an early stage and start lifestyle modifications and treatment as soon as possible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaDiabetes Mellitus, Type 2HumansInsulinOxidative StressInflammation

Stichwörter der Autor:innen

pathophysiologysarcopeniatype 2 diabetes

Substanzen

Insulin

Autor:innen und Institutionen

  • ZNA (ZiekenhuisNetwerk Antwerpen), University Center for Geriatrics, Antwerp, Belgium.
  • Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
  • Department of Endocrinology, Diabetology and Metabolism, Anwerp University Hospital, Edegem, Belgium.

ORCID-Profile: Wouter Tack, Eveline Lia Dirinck

Zitieren

APA

Tack, W., De Cock, A. M., Dirinck, E. L., Bastijns, S., Ariën, F., & Perkisas, S. (2024). Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic options. Diabetes, Obesity and Metabolism, 26(2), 407-416. https://doi.org/10.1111/dom.15321

Vancouver

Tack W, De Cock AM, Dirinck EL, Bastijns S, Ariën F, Perkisas S. Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic options. Diabetes, Obesity and Metabolism. 2024;26(2):407-416. doi:10.1111/dom.15321

BibTeX
@article{Tack2024,
  author = {Tack, Wouter and De Cock, Anne-Marie and Dirinck, Eveline Lia and Bastijns, Sophie and Ariën, Femke and Perkisas, Stany},
  title = {Pathophysiological interactions between sarcopenia and type 2 diabetes: A two‐way street influencing diagnosis and therapeutic options},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {2},
  pages = {407--416},
  doi = {10.1111/dom.15321}
}
Kostenlos starten →